Cargando…
Erratum in: SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587469/ https://www.ncbi.nlm.nih.gov/pubmed/36259679 http://dx.doi.org/10.1167/tvst.11.10.31 |